Navigating the Clinical Trial Process for Hepatocellular Carcinoma

Power Life Sciences

Status: Not yet enrolling

Conditions: Hepatocellular Carcinoma

Study type: Observational

Funder types: Industry

Identifiers

NCT05859945

82127001

Details and patient eligibility

About

Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical study, both positive and negative.

The goal is to identify the obstacles and challenges that prevent participation in hepatocellular carcinoma clinical research, as well as the reasons for withdrawal or discontinuation.

Insights gained from this study will ultimately benefit those with hepatocellular carcinoma who may be invited to participate in clinical research in the years to come.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosed with hepatocellular carcinoma
• Willing to comply with all study related procedures and assessments
• Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol

Exclusion criteria

• No documented diagnosis of hepatocellular carcinoma
• Any serious and/or unstable pre-existing medical disorders
• Pregnant or lactating woman

Trial design